Top stories

Brazil

Afya Reports Second Quarter Net Income of R$201.3 Million

Afya reported second quarter 2026 revenue of R$972.1 million and net income of R$201.3 million, and returned R$447.9 million to shareholders in the first half.

Urban skyline in Belo Horizonte, Brazil

News by Continent

The latest report from each continent we cover.

Middle East

SAPTCO signs SAR 470.2M Jubail school transport contract

Saudi Public Transport Company signed a five year school transport contract in Jubail Industrial City with the Royal Commission for Jubail and Yanbu worth SAR 470,202,973.65 including VAT.

Saudi Arabia

News by Sector

The latest report from each sector we track.

Stocks to Watch

Little-known stocks with breakthrough news, surfaced weekly.

Sernova Biotherapeutics Inc.

Sernova and Seraxis Merge to Form BetaNova Biotherapeutics

Sernova Biotherapeutics Inc. and Seraxis Holdings Inc. have entered a definitive merger agreement to create BetaNova Biotherapeutics, a clinical-stage biotech focused on type 1 diabetes treatments.

Canada
Milestone Pharmaceuticals Inc.

Milestone Pharma Wins First Overseas Approval for Heart Drug

Milestone Pharmaceuticals (Nasdaq: MIST) announced China's regulatory approval of etripamil nasal spray for heart rhythm disorder, marking the first approval of the drug outside the United States.

United States
Monte Rosa Therapeutics

Monte Rosa Receives $50M Milestone for Phase 2 Study

Monte Rosa Therapeutics announced a $50 million milestone payment from Novartis following the initiation of a Phase 2 clinical study for its Sjogren's disease treatment candidate.

United States

Latest News

Monte Rosa Therapeutics headquarters in Boston, United States
United States

Monte Rosa Receives $50M Milestone for Phase 2 Study

Monte Rosa Therapeutics announced a $50 million milestone payment from Novartis following the initiation of a Phase 2 clinical study for its Sjogren's disease treatment candidate.

Market Explainers